Abstract:Epidermal growth factor (EGF) acts as a paracrine and autocrine mediator of cell proliferation and differentiation in various types of epithelial cells, such as sebocytes, which produce the lipid-rich sebum to moisturize the skin. However, sebum lipids via direct contact and by penetrating through the epidermis may have regulatory roles on epidermal and dermal cells as well. As EGF receptor (EGFR) is expressed throughout the proliferating and the lipid-producing layers of sebaceous glands (SGs) in healthy and acne-involved skin, we investigated the effect of EGF on SZ95 sebocytes and how it may alter the changes induced by palmitic acid (PA), a major sebum component with bioactive roles. We found that EGF is not only a potent stimulator of sebocyte proliferation, but also induces the secretion of interleukin (IL)6 and down-regulates the expression of genes involved in steroid and retinoid metabolism. Importantly, when applied in combination with PA, the PA-induced lipid accumulation was decreased and the cells secreted increased IL6 levels. Functional clustering of the differentially regulated genes in SZ95 sebocytes treated with EGF, PA or co-treated with EGF+PA further confirmed that EGF may be a potent inducer of hyperproliferative/inflammatory pathways (IL1 signaling), an effect being more pronounced in the presence of PA. However, while a group of inflammatory genes was up-regulated significantly in EGF+PA co-treated sebocytes, PA treatment in the absence of EGF, regulated genes only related to cell homeostasis. Meta-analysis of the gene expression profiles of whole acne tissue samples and EGF- and EGF+PA -treated SZ95 sebocytes showed that the EGF+PA co-activation of sebocytes may also have implications in disease. Altogether, our results reveal that PA-induced lipid accumulation and inflammation can be modulated by EGF in sebocytes, which also highlights the need for system biological approaches to better understand sebaceous (immuno)biology.

Acne vulgaris: proliferative cells in sebaceous glands

Sebum analysis of individuals with and without acne.

Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis

Beyond acne: Current aspects of sebaceous gland biology and function

Primary sebocytes and sebaceous gland cell lines for studying sebaceous lipogenesis and sebaceous gland diseases

[Sebaceous Glands and Acne].

Androgen metabolism in sebaceous glands from subjects with and without acne

907 Propionibacterium Acnes and Peptidoglycan Reduce Lipidgenesis and Change Differentiation of SZ95 Human Sebocytes in Vitro Via Aryl Hydrocarbon Receptor

Sebocyte differentiation as a new target for acne therapy: an in vivo experience

Immunolocalization of 5alpha-reductase isozymes in acne lesions and normal skin

Tracing the cellular dynamics of sebaceous gland development in normal and perturbed states

A spatial portrait of the human sebaceous gland transcriptional program

Sebaceous Gland Activity in Atopic Eczema

Epidermal Growth Factor Modulates Palmitic Acid-Induced Inflammatory and Lipid Signaling Pathways in SZ95 Sebocytes

New developments in our understanding of acne pathogenesis and treatment

Frontiers in sebaceous gland biology and pathology

Expression of sex‐determining genes in human sebaceous glands and their possible role in the pathogenesis of acne

Development of new 3D human ex vivo models to study sebaceous gland lipid metabolism and modulations

In vitro acne disease model from inertial focusing effect for studying the interactions between sebocyte glands and macrophages

Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition

[Differentiation of various Propionibacterium species from acne-vulgaris efflorescences]